Medical Equipment

Smart Biopsy Devices Market Forecast Covering Industry Demand And Market Evolution

May 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Smart Biopsy Devices Market During The 2026–2030 Period?

The smart biopsy devices market size has experienced substantial growth in recent years. It is projected to expand from $3.01 billion in 2025 to $3.23 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historical growth can be largely ascribed to increasing cancer incidence rates, a rise in the use of minimally invasive diagnostic procedures, the expansion of advanced imaging infrastructure, the growing adoption of core needle biopsy techniques, and improved clinician training in image-guided diagnostics.

The smart biopsy devices market is poised for significant expansion over the coming years. This market is projected to reach $4.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth is driven by several factors, including a greater need for precision oncology diagnostics, increased spending on intelligent surgical technologies, the development of robotic-assisted intervention platforms, a heightened emphasis on early disease identification, and the increasing incorporation of AI-powered diagnostic assistance. Key developments anticipated during this period involve the wider acceptance of image-guided biopsy systems, a surge in the application of robotic-assisted biopsy procedures, the increasing incorporation of real-time tissue feedback technologies, the proliferation of minimally invasive diagnostic methods, and a sharpened emphasis on diagnostic precision and patient well-being.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

What Primary Factors Are Fueling The Expansion Of The Smart Biopsy Devices Market?

Increasing instances of cancer are anticipated to drive the expansion of the smart biopsy devices market in the future. Cancer encompasses a wide range of diseases that may emerge in almost any organ or tissue, characterized by the uncontrolled multiplication of abnormal cells that surpass their normal confines, potentially spreading to other organs or invading adjacent tissues. This growth in cancer diagnoses has heightened the demand for precise and targeted tissue specimens. Consequently, this has spurred the development and refinement of smart biopsy instruments, equipping them with enhanced molecular, imaging, and precision features crucial for improved diagnosis and treatment strategies. As an illustration, the World Health Organization, an intergovernmental body based in Switzerland, reported in January 2024 a projection of more than 35 million new cancer cases by 2050. This represents a substantial 77% surge compared to the approximately 20 million cases and 9.7 million deaths documented in 2022. Thus, the increasing prevalence of cancer is propelling the expansion of the smart biopsy device market.

Which Segment Divisions Form The Structure Of The Smart Biopsy Devices Market?

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Localization Wires

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

What Trends Are Influencing The Future Of The Smart Biopsy Devices Market?

Leading companies operating in the smart biopsy devices market are concentrating on developing advanced solutions, such as multi-modality breast biopsy markers, with the goal of improving lesion localization, enabling long-term site visibility, and enhancing diagnostic confidence. These multi-modality markers are specialized biopsy site indicators engineered to remain clearly visible across ultrasound, mammography, and MRI, assisting clinicians in accurately tracking biopsy locations and supporting precise follow-up assessments. For instance, in March 2024, Mammotome, a U.S.-based medical technology company, launched LumiMARK, its next-generation 510(k)-cleared breast biopsy site marker designed for multi-modality identification. Available in three distinct 3D shapes—including Tulip™ and Rose™—the marker provides consistent visibility across imaging modalities and offers improved long-term detectability in both breast tissue and lymph nodes, thereby supporting more accurate diagnosis and ongoing clinical decision-making.

Who Are The Leading Firms Participating In The Smart Biopsy Devices Market?

Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation

Access The Complete Smart Biopsy Devices Market Report:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Which Region Has The Strongest Presence In The Smart Biopsy Devices Market?

North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Smart Biopsy Devices Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Browse Through More Reports Similar to the Global Smart Biopsy Devices Market 2026, By The Business Research Company

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Patient Monitoring Devices Market 2026

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795